Precigen, Inc. (PGEN)
6.85
+0.17
(+2.54%)
USD |
NASDAQ |
Sep 11, 16:00
6.82
-0.03
(-0.44%)
After-Hours: 20:00
Precigen Price : 6.85 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 6.77 | 6.92 | 6.76 | 6.85 | 2.061M |
| Sep 10, 2026 | 6.70 | 6.73 | 6.54 | 6.68 | 2.839M |
| Sep 09, 2026 | 6.87 | 6.885 | 6.675 | 6.80 | 3.138M |
| Sep 08, 2026 | 6.89 | 7.02 | 6.72 | 6.87 | 2.771M |
| Sep 04, 2026 | 7.12 | 7.27 | 7.08 | 7.10 | 2.193M |
| Sep 03, 2026 | 7.00 | 7.14 | 6.98 | 7.14 | 2.189M |
| Sep 02, 2026 | 6.91 | 7.14 | 6.815 | 7.01 | 2.638M |
| Sep 01, 2026 | 6.81 | 7.00 | 6.80 | 6.86 | 2.806M |
| Aug 31, 2026 | 6.934 | 7.00 | 6.602 | 6.93 | 4.136M |
| Aug 28, 2026 | 7.11 | 7.19 | 6.92 | 6.95 | 2.703M |
| Aug 27, 2026 | 7.435 | 7.46 | 7.14 | 7.19 | 4.977M |
| Aug 26, 2026 | 7.66 | 7.715 | 7.28 | 7.42 | 7.409M |
| Aug 25, 2026 | 7.29 | 7.55 | 7.23 | 7.28 | 5.842M |
| Aug 24, 2026 | 7.15 | 7.205 | 6.93 | 7.17 | 3.350M |
| Aug 21, 2026 | 7.50 | 7.50 | 7.10 | 7.20 | 4.406M |
| Aug 20, 2026 | 7.06 | 7.49 | 6.975 | 7.44 | 7.838M |
| Aug 19, 2026 | 6.97 | 7.21 | 6.80 | 7.16 | 8.153M |
| Aug 18, 2026 | 6.42 | 6.79 | 6.34 | 6.75 | 4.356M |
| Aug 17, 2026 | 6.165 | 6.78 | 6.10 | 6.55 | 6.278M |
| Aug 14, 2026 | 6.32 | 6.395 | 6.08 | 6.10 | 7.960M |
| Aug 13, 2026 | 6.97 | 6.97 | 6.455 | 6.49 | 5.533M |
| Aug 12, 2026 | 6.88 | 6.95 | 6.65 | 6.85 | 4.424M |
| Aug 11, 2026 | 7.10 | 7.10 | 6.75 | 6.86 | 4.876M |
| Aug 10, 2026 | 7.21 | 7.32 | 6.975 | 7.00 | 4.753M |
| Aug 07, 2026 | 7.05 | 7.26 | 6.93 | 7.23 | 5.759M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Aldeyra Therapeutics, Inc. | 1.34 |
| Anika Therapeutics, Inc. | 20.86 |
| AC Immune SA | 2.76 |
| Geron Corp. | 1.35 |
| Neurocrine Biosciences, Inc. | 156.22 |
Price Related Metrics
| PS Ratio | 28.55 |
| PEG Ratio | -0.0398 |
| Price to Book Value | 56.28 |
| Earnings Yield | -16.05% |
| Market Cap | 2.452B |
| PEGY Ratio | -0.0398 |